In a preclinical study, researchers found tamoxifen encourages uterine cell growth; the findings could change how some breast ...

In a preclinical study, researchers found tamoxifen encourages uterine cell growth; the findings could change how some breast cancers are treated in the future ...

In a preclinical study, researchers found tamoxifen encourages uterine cell growth; the findings could change how some breast ...

Studies show that people receiving tamoxifen, a highly effective and commonly used therapy to treat breast cancer, face a 2- ...

Loni Anderson's cause of death was metastatic uterine leiomyosarcoma, a rare and aggressive form of cancer. She passed away ...

An international research team has identified a previously unknown mechanism by which the breast cancer drug tamoxifen can ...

People with obesity who take weight loss and diabetes drugs like Ozempic and Mounjaro could face a lower risk of cancer ...

The National Cancer Institute of the National Institutes of Health has awarded Dr. Anna Gottschlich, assistant professor of oncology in the Wayne State University School of Medicine and the Barbara ...

Loni Anderson’s cause of death has been confirmed as a rare and aggressive form of uterine cancer that occurs in just 6 out ...

The intervention being tested is BNT323/DB-1303, an investigational drug administered via intravenous infusion. It is compared against standard chemotherapy options, doxorubicin or paclitaxel, chosen ...

The interventions being tested include Trastuzumab deruxtecan (T-DXd), an experimental therapy, combined with either Rilvegostomig or Pembrolizumab, both administered via intravenous infusion. These ...

GLP-1 agonist users had a 17% lower cancer risk compared to non-users in a large retrospective study. The reductions achieved ...